Ginkgo Bioworks Holdings Inc vs Payoneer Global Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Payoneer Global Inc is far larger — about 4.7× Ginkgo Bioworks Holdings Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | PAYO | |
|---|---|---|
Market Cap | $505.73M | $2.40B |
Sector | Health | Technology |
52-Week High | $16.14 | $7.17 |
52-Week Low | $5.48 | $4.27 |
Enterprise Value | $607.68M | $2.14B |
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →